Share on StockTwits
Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

Investor Ideas Potcasts, Cannabis News and Stocks on the Move May 1st (CSE: CURA) (OTCQX: CURLF), (CSE: CXXI) (CSE: SPR) (OTC: SRUTF)

News from Province Brands, HelloMD, Panaxia Pharmaceutical Industries Israel

 

Delta, Kelowna, BC - May 1, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/050119-StocksToWatch.mp3

Investor Ideas Potcasts, #Cannabis News and Stocks on the Move May 1st (CSE: CURA) (OTCQX: CURLF), (CSE: CXXI) (CSE: SPR) (OTC: SRUTF)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:

Good morning and welcome to another episode of Investorideas.com "potcasts", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast I focus on a few early announcements from some interesting companies.

But first, HelloMD will now provide patients in Canada with convenient access to practitioner-led advice about medical cannabis through a new relationship with Shoppers Drug Mart's online medical cannabis platform.

Since its launch in 2015, HelloMD's turnkey telehealth platform has facilitated more than 100,000 virtual consults between medical cannabis patients and licensed practitioners. HelloMD is currently active in Canada and the United States.

The Medical Cannabis by Shoppers website now features a dedicated portal operated by HelloMD. Patients can access live video consultations with licensed healthcare practitioners through the dedicated portal seven days a week, from the comfort of their home.

Following a consultation with a healthcare practitioner, patients that receive a medical document authorizing their registration as a medical cannabis patient may return to the Medical Cannabis by Shoppers website to register and begin choosing from its wide selection of approved products, or direct HelloMD to send their medical document to an alternative licensed producer.

Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis company. According to the agreement, the parties will co-develop the next generation of medical cannabis products intended for patients suffering from Inflammatory Bowel Disease, and who are authorized to receive treatment with medical cannabis. The treatment consists of medical cannabis suppositories, which contain a proprietary composition based on a combination of defined and precise active ingredients from the cannabis plant. The novelty lies in the fact that for the first time, a medical cannabis product will be developed in order to offer a targeted solution to patients suffering from Crohn's disease and Colitis, in order to decrease the level of inflammation in the intestine.

Inflammatory bowel disease (Crohn's or Ulcerative Colitis) are chronic diseases that can appear at any age. Now for the first time, treatment with medical cannabis for these patients will be delivered utilizing an accepted, conventional pharmaceutical delivery system, and which is based on clinical research. This will offer a potential solution and increase accessibility of the treatment to a greater number of patients who need it and are eligible to receive it.

The active ingredients in the rectal cannabis suppositories are absorbed at a relatively fast rate through the many blood vessels and are not first metabolized by the liver, unlike medications that are taken orally. As a result, the biological availability of the active ingredients rises on the one hand, and a speedy physical response occurs on the other hand.

According to Dr. Dadi Segal, Panaxia CEO, "Panaxia has already gained proven and successful experience with cannabis suppositories in the American market. The agreement that was signed today is an additional milestone in revolutionizing accessibility of medical cannabis also in Israel, which we are leading together with Rafa. By enabling cannabis accessibility via traditional pharmaceutical delivery systems, and which are not based on smoking, we are striving to enable patients who are eligible for medical cannabis treatment, for a wide range of diseases, to be able to benefit from its unique attributes, subject at all times to the advice of a qualified medical specialist."

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced it has signed a definitive agreement to acquire the state-regulated cannabis business of Cura Partners, Inc., owners of the Select brand, in an all-stock transaction valued at C$1.27 billion or US$948.8 million.

The acquisition includes Select's manufacturing, processing, distribution, marketing and retailing operations and all adult-use cannabis products marketed under the Select brand name, including all intellectual property. Based in Portland, Oregon, Select is the most well-known cannabis wholesale brand in the country. With its THC products sold in more than 900 retailers, it is the leading cannabis brand in key Western states, including California, Arizona, Oregon and Nevada.

The highly complementary acquisition brings together two of the strongest cannabis brands, Curaleaf and Select, to offer a full-range of products across the U.S. The combination will provide immediate geographic diversification with Curaleaf's footprint on the East Coast and Select's brand strength on the West Coast.

The proposed transaction combines Curaleaf's retail locations, vertical integration, wellness brand and strong East Coast market presence with Select's wholesale model, lifestyle brand and leading West Coast market presence. Significant cost synergies are expected to be realized through operational efficiencies, greater economies of scale, supply chain efficiencies and increased vertical integration.

C21 Investments, Inc. (CSE: CXXI) today announced the launch of a new product: the Phantom Vape Pen. The highly anticipated vape pen solves a number of industry challenges by providing uniform viscosity, shelf stability, oil clarity as well as consistency of flavour and potency.

"Vaping is the main driver of concentrate sales, which are projected to reach $8.4 billion in USA sales by 2022," said Sky Pinnick, Chief Marketing Officer, C21 Investments. "Our strategy for the Phantom Vape Pen was to provide an affordable, superior product at a highly competitive price point helping to bridge the gap for flower traditionalists to high quality concentrates."

The Phantom Vape Pen is made by Phantom Farms, a Clean Green Certified cannabis cultivator in Oregon. Using the industry leading CCELL technology with Phantom Farms proprietary terpene-heavy CO2 + distillate extract formulation, the Phantom Vape Pen provides native flavour (terpene) retention, and consistent potency and vaporization experience.

Sproutly Canada, Inc. (CSE: SPR) (OTC: SRUTF), and OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited, announced that they have entered into a definitive agreement to form an exclusive joint venture to develop, produce, and market non‐alcoholic cannabis-infused beverages in Canada using Sproutly's proprietary, naturally produced water soluble cannabinoids known as 'Infuz2O'. Both companies will bring their respective strengths to the joint venture to develop a line of great tasting cannabis beverages featuring a rapid onset and offset effect unique to the category. Sproutly also hosted a conference call with Keith Dolo, CEO, Sproutly Canada and Matthew Oland, Moosehead executive and incoming CEO of the JV, at 9:30am Eastern Time this morning on May 1, 2019.

Dooma Wenshuh, CEO and Co-Founder of Province Brands commented on this announcement, saying "We are delighted to see the excitement and build-up to the next phase of cannabis legalization in Canada later this year. With today's news of Sproutly & Moosehead coming after recent match-ups from AB InBev & Tilray, Constellation Brands & Canopy Growth, Heineken & CannaCraft, and Molson-Coors & Hexo there can be little doubt that beverages will be the dominant form of cannabis consumption in the years ahead."

"Above these headlines, Province Brands of Canada continues to stand out as the only beverage maker that will deliver beer brewed entirely from the cannabis plant, not an infused concoction, thus providing consumers with the experience of authenticity, high-quality, and choice that they demand."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Sign up to get the news alerts including the daily podcast and transcript for Investor ideas podcasts

Subscribe to the new cannabis podcast series:

https://www.investorideas.com/rss/feeds/Podcasts-Cannabis.xml

Or visit https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/potcasts_investorideas/

Contact Investorideas.com

800-665-0411



Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories